CClinicalTrials.gg
RecruitingNCT06485323Pelvi-MRIUpdated Apr 29, 2026

MRI Pseudo-CT Sequences for Obstetrical Pelvimetry.

An interventional study of MRI pelvimetry in Obstetric Labor Complications, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Recruiting at 1 site in Belgium. Open to female participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jul 2023, registered May 2024).
  • Started Jul 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
95
Allocation
Not applicable
Ages
18 Years to 99 Years
Sex
Female
01

Study summary

It is possible to perform a pelvimetry by MRI as a substitute to pelvimetry by CT, hence sparing the patient from a dose of irradiation.

Read the detailed description

The Principal investigator want to evaluate new MRI sequences offering both an optimal contrast between mineral bone and soft tissues, and a shorter acquisition time. Indeed, the recent developments of specific MRI sequences to preferentially image the mineral bone (namely the ZTE and lavaflex 3D T1-weighted SPGR sequences) allow performing pelvimetry measurements on MR images offering an optimal "pseudo CT" contrast, with an MR acquisition time that is less than 10 minutes. Preliminary tests of these sequences have been carried out in our center in order to be able to implement these sequences on our clinical and research MRI machines. The study team wish to undertake a study to validate the use of this rapid and non-irradiating MRI approach, with the aim to replace a CT pelvimetry by a MRI pelvimetry demonstrated as being as reliable.

02

Conditions studied

  • Obstetric Labor Complications

Keywords

  • technological progress
03

In context

Obstetric Labor Complications

89 studies on the registry are indexed under Obstetric Labor Complications; 25 are open to participants now.

This study's planned enrollment of 95 is below the median of 150 across 63 interventional studies indexed under Obstetric Labor Complications.

Browse Obstetric Labor Complications studies →

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the lead sponsor of 342 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Pregnant woman 33 to 41 week
  • Woman who gave birth by cesarean section, for whom the obstetrician requests a pelvimetry CT for the next pregnancy
  • Pelvimetry planned by the obstetrical team outside of "emergency" pathway
  • Adhere to the study protocol after reading the patient information document have signed the informed consent form to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Usual contraindications to MRI (Pacemaker, Metallic foreign body, Cochlear implant,…)
  • Severe claustrophobia
  • uncomfortable back position
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
95 participants (estimated)

Study arms

  • Experimental
    IRM + CT scan for Pelvimetry

    Device: MRI pelvimetry

Interventions

  • DeviceMRI pelvimetry

    MRI of the pelvis

06

What researchers measure

Primary outcomes

  1. Prove the non-inferiority of MRI compared to CT for pelvimetry.

    Measurement of pelvic bone diameters in pregnant women

    Time frame: 30 minutes (duration of the exam+ measurement)

Secondary outcomes

  1. Evaluate patient convenience for both examinations (CT and MRI)

    questionnaire (scale from zero to ten, zero = more pleasant, ten=least pleasant)

    Time frame: immediately after both examinations

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Hampel F, Hallscheidt P, Sohn C, Schlehe B, Brocker KA. Pelvimetry in nulliparous and primiparous women using 3 Tesla magnetic resonance imaging. Neurourol Urodyn. 2018 Aug;37(6):1950-1956. doi: 10.1002/nau.23537. Epub 2018 Feb 21. PubMed 29464757 ↗
  • Li J, Lou Y, Chen C, Zheng W, Chen Y, Dong T, Yang M, Zhao B, Luo Q. Predictive Value of MRI Pelvimetry in Vaginal Delivery and Its Practicability in Prolonged Labour-A Prospective Cohort Study. J Clin Med. 2023 Jan 5;12(2):442. doi: 10.3390/jcm12020442. PubMed 36675370 ↗
  • Liao KD, Yu YH, Li YG, Chen L, Peng C, Liu P, Chen CL, Chen RY, Zhong M, Wang Y. Three-dimensional magnetic resonance pelvimetry: A new technique for evaluating the female pelvis in pregnancy. Eur J Radiol. 2018 May;102:208-212. doi: 10.1016/j.ejrad.2018.03.024. Epub 2018 Mar 19. PubMed 29685537 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06485323
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Responsible party
Sponsor
First posted
Jul 3, 2024
Start date
Jul 5, 2023
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Apr 29, 2026

Study contacts

Frédéric Lecouvet, MD, PhD
Contact
frederic.lecouvet@saintluc.uclouvain.be
+3227642793
Frédéric Lecouvet, MD, PhD
principal investigator · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion